Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The alpha-1 adrenergic receptor (α1-adrenergic receptor) is a G protein-coupled receptor that is primarily activated by norepinephrine and epinephrine. It mediates physiological responses to sympathetic nervous system activation, including vasoconstriction, smooth muscle contraction, and neurotransmission. There are three subtypes: α1A, α1B, and α1D. Drugs targeting alpha-1 adrenergic receptors include agonists and antagonists, used for conditions such as hypertension and benign prostatic hyperplasia.
Activation of Gq/11 proteins leading to phospholipase C activation and increased intracellular calcium levels.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-1 Adrenergic Receptor (α1-AR).